In early February 2017, our partners returned to St. Louis to begin their fourth talcum powder trial, which was a “Defense pick.”
Our Plaintiff in the case was Nora Daniels, who was diagnosed with ovarian cancer in May 2013 after having used Johnson and Johnson talcum powder products for more than 30 years. On March 3rd, 2017, after a multi-week trial, the jury returned a Defense verdict for both Johnson & Johnson and Imerys Talc America, the manufacturer that supplies talc to Johnson & Johnson. This was the first time a jury decided in favor of Johnson & Johnson.
As you may recall, three previous St. Louis juries returned verdicts for the Plaintiff and awarded damages totaling nearly $200 million. While disappointed with the outcome in this case, we continue to evaluate and file cases on behalf of women who were diagnosed with ovarian cancer after using Johnson & Johnson Baby Powder and/or Shower to Shower products. We feel badly for Ms. Daniels and know what she has gone through.
Four additional talc trials are currently set to take place in St. Louis later this year. Additional trials are scheduled in Washington, D.C and California later this year. Our partners will return to St. Louis to begin our fifth St. Louis talcum powder trial on April 10th. Our Plaintiff in this case is a 61 year old Virginia resident, who was diagnosed with ovarian cancer in August 2012 after using Johnson & Johnson talcum powder products for more than 40 years. This trial, like the prior trial, is also a “defense pick”. We also have another talc trial in St. Louis scheduled for June 2017. Our lawyers look forward to trying both of these cases.